New Key Statistics Module, Z-Score and F-Score
NAS:ADMA Key Ratios
Market Cap $ M | 2,100.19 |
Enterprise Value $ M | 2,205.57 |
P/E(ttm) | -- |
PE Ratio without NRI | 94.79 |
Forward PE Ratio | 30.35 |
Price/Book | 13.73 |
Price/Sales | 7.33 |
Price/Free Cash Flow | 126.39 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 283.00 |
EPS (TTM) $ | -0.02 |
Beneish M-Score | -1.89 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 112.35 |
EV-to-EBITDA | 78.65 |
PEG | -- |
Shares Outstanding M | 231.81 |
Net Margin (%) | -1.29 |
Operating Margin % | 15.63 |
Pre-tax Margin (%) | -1.08 |
Quick Ratio | 1.86 |
Current Ratio | 5.21 |
ROA % (ttm) | -1.06 |
ROE % (ttm) | -2.49 |
ROIC % (ttm) | 21.94 |
Dividend Yield % | -- |
Altman Z-Score | 6.23 |
ADMA Number of Guru Trades
ADMA Volume of Guru Trades
Gurus Latest Trades with NAS:ADMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ADMA is held by these investors
Total 2
ADMA Biologics Inc Insider Transactions
No Available Data
News about NAS:ADMA
Total 0- 1